Clinical Trial Update: IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining IL-7 and IL-7R expression in rheumatoid arthritis patients with active vs inactive disease who are treated with DMARDs o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2024-07-10